Operating Metrics 營運指標
Gilead Sciences, Inc. (GILD) Operating Metrics 營運指標
Gilead Sciences, Inc. GILD 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-03-31
最新營運指標
- Total Product Sales
- 29,248 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- HIV Product Sales
- 21,196 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Liver Disease Product Sales
- 3,225 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Oncology Product Sales
- 3,289 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Veklury Sales
- 754 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Biktarvy Sales
- 14,600 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Descovy Sales
- 2,980 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
- Cell Therapy Product Sales
- 1,782 USD M · 2026-03-31 來源：Gilead Sciences、Gilead Sciences、Gilead Sciences、Gilead Sciences
季度趨勢
| 指標 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Total Product Sales | 6,946 USD M | 7,903 USD M | 7,345 USD M | 7,054 USD M | 6,613 USD M | 7,536 USD M | 7,515 USD M | 6,912 USD M |
| HIV Product Sales | 5,030 USD M | 5,801 USD M | 5,277 USD M | 5,088 USD M | 4,587 USD M | 5,452 USD M | 5,073 USD M | 4,745 USD M |
| Liver Disease Product Sales | 767 USD M | 844 USD M | 819 USD M | 795 USD M | 758 USD M | 719 USD M | 733 USD M | 832 USD M |
| Oncology Product Sales | 810 USD M | 842 USD M | 788 USD M | 849 USD M | 757 USD M | 843 USD M | 816 USD M | 841 USD M |
| Veklury Sales | 144 USD M | 212 USD M | 277 USD M | 121 USD M | 302 USD M | 337 USD M | 692 USD M | 214 USD M |
| Biktarvy Sales | 3,400 USD M | 4,000 USD M | 3,700 USD M | 3,500 USD M | — | — | — | — |
| Descovy Sales | 807 USD M | 819 USD M | 701 USD M | 653 USD M | — | — | — | — |
| Cell Therapy Product Sales | 407 USD M | 458 USD M | 432 USD M | 485 USD M | — | — | — | — |
| Trodelvy Sales | 402 USD M | — | 357 USD M | 364 USD M | — | — | — | — |
| Product Gross Margin | 79.2% | 79.5% | 78.6% | 78.7% | 76.7% | 79.0% | 79.1% | 77.7% |
資料來源
- Gilead Sciences Announces First Quarter 2026 Financial Results · Gilead Sciences · 2026-05-07
- Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results · Gilead Sciences · 2026-02-10
- Gilead Sciences Announces Third Quarter 2025 Financial Results · Gilead Sciences · 2025-10-30
- Gilead Sciences Announces Second Quarter 2025 Financial Results · Gilead Sciences · 2025-08-07